400-920-2911 sales@csnpharm.cn
CAS No.: 224624-80-0
Synonyms: CPHPC;Ro63-8695;GSK2315698
Miridesap is an antineoplastic which depletes circulating serum amyloid P component (SAP) almost completely but leaves some SAP in amyloid deposits for specific recognition by subsequently administered therapeutic anti-SAP antibodies.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT03417830 | Amyloidosis | Phase 1 | Terminated(Change in benefit/r... more >>isk profile.) Collapse << | - | Sweden ... more >> GSK Investigational Site Uppsala, Sweden, SE-751 85 GSK Investigational Site Uppsala, Sweden, SE-751 Collapse << |
NCT03567499 | Amyloidosis | Phase 1 | Withdrawn(The decision to end ... more >>the study was made for GSK portfolio reasons. No subjects were randomised into the study.) Collapse << | May 3, 2019 | United Kingdom ... more >> GSK Investigational Site London, United Kingdom, NW10 7EW Collapse << |
实验方案
技术信息
CAS号 | 224624-80-0 | 储存条件 |
|
|||||
分子式 | C16H24N2O6 | 运输 | 蓝冰 | |||||
分子量 | 340.37 | 别名 | CPHPC;Ro63-8695;GSK2315698 | |||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT03417830 | Amyloidosis | Phase 1 | Terminated(Change in benefit/r... more >>isk profile.) Collapse << | - | Sweden ... more >> GSK Investigational Site Uppsala, Sweden, SE-751 85 GSK Investigational Site Uppsala, Sweden, SE-751 Collapse << |
NCT03567499 | Amyloidosis | Phase 1 | Withdrawn(The decision to end ... more >>the study was made for GSK portfolio reasons. No subjects were randomised into the study.) Collapse << | May 3, 2019 | United Kingdom ... more >> GSK Investigational Site London, United Kingdom, NW10 7EW Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网